Status:

COMPLETED

Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)

Lead Sponsor:

Aerie Pharmaceuticals

Conditions:

Dry Eye Disease

Eligibility:

All Genders

30+ years

Phase:

PHASE3

Brief Summary

This will be a Phase 3, multicenter, vehicle-controlled, double-masked, randomized study conducted at approximately 20 sites in the United States. All subjects enrolled will have dry eye disease (DED)...

Detailed Description

At the end of the Screening Visit, all qualified subjects will be assigned to administer one drop of AR-15512 Vehicle twice a day to both eyes for approximately 14 days (vehicle run-in period). After ...

Eligibility Criteria

Inclusion

  • Key
  • Signs and symptoms of dry eye disease (DED) at the Screening and Baseline visits;
  • Corrected visual acuity of +0.70 logarithm Minimum angle of resolution (LogMAR) or better in both eyes at Screening and Baseline visits;
  • Other protocol-specified inclusion criteria may apply.
  • Key

Exclusion

  • History or presence of any ocular disorder or condition (other than DED) in either eye that would, in the opinion of the investigator, likely interfere with the interpretation of the study results or subject safety;
  • Regular use of lid hygiene within 14 days prior to the Screening visit or any planned use during the study;
  • Use of artificial tears within 2 hours prior to the Screening visit or anticipated use during the study;
  • Medication use as specified in the protocol;
  • History or presence of significant systemic disease;
  • Other protocol-specified exclusion criteria may apply.

Key Trial Info

Start Date :

July 18 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 17 2023

Estimated Enrollment :

467 Patients enrolled

Trial Details

Trial ID

NCT05360966

Start Date

July 18 2022

End Date

October 17 2023

Last Update

July 23 2025

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

Reeve Woods Eye Center

Chico, California, United States, 95926

2

NVision Clinical Research, LLC

Fullerton, California, United States, 92835

3

Eye Research Foundation

Newport Beach, California, United States, 92663

4

Shultz Vision

Northridge, California, United States, 91325